BIOSTATISTICS & COMPUTATIONAL BIOLOGY (BCB) Quantitative and data sciences have penetrated nearly all aspects of biomedical research. With that comes challenges and opportunities to develop the methods needed to make valid and efficient use of these data for inference on human health and medicine. The Biostatistics & Computational Biology (BCB) Program provides the intellectual environment for advancing these efforts. Our research program portfolio spans a broad range of activities from statistical methods development to biological research that uses experimental studies in conjunction with computational methods. Our statistical research emphasizes analytic approaches to genome-scale data sets, molecular diagnostics, development and applications of objective measures of lifestyle and environmental exposures, and methods for clinical trials. Highlights include breakthroughs in prostate and colorectal cancer screening analysis, new methods for design and analysis of therapeutic trials, and the development of new statistical approaches for precision medicine and biomarker discovery. Biological research is concentrated on cancer-relevant aspects of quantitative immune profiling, infectious disease/microbiome, and basic molecular biology. BCB members have identified new therapeutic avenues for treatment of leukemias and novel predictive markers of immunotherapy response. Our research is characterized by a productive interplay between applied work and methods development.
Our specific aims are to develop rigorous statistical and mathematical methods relevant to predictive and personalized medicine; to develop and use experimental, technological, and companion computational or mathematical methods to gain understanding of the natural history of cancer, and to develop and disseminate statistical and computational methods in cancer research. A substantial portion of our research is in areas of emphasis such as high-dimensional data analysis, immune profiling, mobile device data, and machine learning that were not a major focus 5 years ago. The ongoing growth and development of high-throughput technologies for acquiring biological data provides great opportunities and challenges for statisticians and computational researchers to make impactful contributions in cancer research. BCB members are well-positioned to capitalize on these exciting opportunities: we have a wide range of quantitative methodological training augmented by cancer-relevant domain knowledge; we have outstanding collaborations; we are strongly committed to translating our methods research into new diagnostic tools and therapies; and we are attentive to emerging opportunities in biomedical data science.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-46
Application #
10125976
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-01
Project End
2024-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Gauthier, Jordan; Turtle, Cameron J (2018) Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy. Curr Res Transl Med 66:50-52
Graves, Scott S; Parker, Maura H; Stone, Diane et al. (2018) Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:50-54
Méndez, Eduardo; Rodriguez, Cristina P; Kao, Michael C et al. (2018) A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 24:2740-2748
Amundsen, Susan K; Smith, Gerald R (2018) The RecB helicase-nuclease tether mediates Chi hotspot control of RecBCD enzyme. Nucleic Acids Res :
Montgomery, Elizabeth T; Noguchi, Lisa M; Dai, James Y et al. (2018) Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States. AIDS Behav 22:402-411
Buckley, Sarah A; Percival, Mary-Elizabeth; Othus, Megan et al. (2018) A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study. Leuk Lymphoma :1-7
Rañola, John Michael O; Liu, Quanhui; Rosenthal, Elisabeth A et al. (2018) A comparison of cosegregation analysis methods for the clinical setting. Fam Cancer 17:295-302
Talarico, Sarah; Leverich, Christina K; Wei, Bing et al. (2018) Increased H. pylori stool shedding and EPIYA-D cagA alleles are associated with gastric cancer in an East Asian hospital. PLoS One 13:e0202925
Zhao, Shanshan; Leonardson, Amy; Geybels, Milan S et al. (2018) A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. Prostate :
Greenbaum, Adam M; Green, Damian J; Holmberg, Leona A et al. (2018) Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma. Blood Res 53:223-226

Showing the most recent 10 out of 1267 publications